Authors

• Bronno van der Holt (ORCID: https://orcid.org/0000-0001-6414-2671)
• Mario Boccadoro (ORCID: https://orcid.org/0000-0001-8130-5209)
• Jeroen J. W. M. Janssen (ORCID: https://orcid.org/0000-0001-9567-1955)
• Paula F. Ypma (ORCID: https://orcid.org/0000-0003-1250-7979)
• N Maas (ORCID: https://orcid.org/0009-0006-9751-8122)
• Jurjen Versluis
• Yvette van Norden
• Bob Löwenberg (ORCID: https://orcid.org/0000-0001-8982-5217)
• Pieter Sonneveld
• Erik D. van Werkhoven (ORCID: https://orcid.org/0000-0001-7469-7427)
• Jan J. Cornelissen (ORCID: https://orcid.org/0000-0002-1864-4598)
• Annette Juul Vangsted (ORCID: https://orcid.org/0000-0002-2131-731X)
• Fredrik Schjesvold (ORCID: https://orcid.org/0000-0003-1096-0569)
• Sonja Zweegman (ORCID: https://orcid.org/0000-0002-5011-1820)
• Gert Jan Ossenkoppele
• A. J. Smit
• Heleen A. Visser-Wisselaar
• Rossella Troia

Institutions

• Oslo University Hospital (NO)
• Radboud University Nijmegen (NL)
• Erasmus MC (NL)
• Rigshospitalet (DK)
• European Heart Network (BE)
• Amsterdam Neuroscience (NL)
• Haga Hospital (NL)
• Hovon (NL)
• Erasmus MC Cancer Institute (NL)
• Amsterdam University Medical Centers (NL)
• University of Amsterdam (NL)

Publication Details

Journal

Haematologica

Published

2025-10-02

DOI

https://doi.org/10.3324/haematol.2025.288675

Primary Topic

Statistical Methods in Clinical Trials

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Bristol-Myers Squibb
• GlaxoSmithKline
• Sanofi
• Celgene